Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 20 von 127

Details

Autor(en) / Beteiligte
Titel
Aberrant NF-κB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts
Ist Teil von
  • Oncogene, 2005-06, Vol.24 (24), p.3976-3986
Ort / Verlag
Basingstoke: Nature Publishing
Erscheinungsjahr
2005
Quelle
Free E-Journal (出版社公開部分のみ)
Beschreibungen/Notizen
  • Overexpression of CD30 and constitutive nuclear factor-κB (NF-κB) activation are hallmarks of the malignant Hodgkin Reed–Sternberg (H-RS) cells. Previous investigations have demonstrated that both proliferation and survival of H-RS cells require constitutive NF-κB activity, which is comprised of the p50 and RelA subunits. We report here enhanced expression of NF-κB2/p52 and RelB-containing NF-κB DNA-binding activity in Epstein–Barr virus-negative H-RS cells. Kinetic studies revealed that a proteasome inhibitor MG132 induced p100 accumulation with reduced p52 expression in H-RS cells, suggesting proteasome-dependent processing of p100. In addition, treatment with a protein synthesis inhibitor cycloheximide rapidly downregulated inhibitor of NF-κB (IκB) kinase activity in H-RS cells. We also demonstrate that overexpression of CD30 in rat fibroblasts at levels comparable to those in H-RS cells results in constitutive IκB kinase activation, proteasome-dependent p100 processing, and NF-κB-dependent cell transformation. Our results thus indicate that CD30 triggers the noncanonical NF-κB activation pathway, and suggest that deregulated CD30 signaling contributes to the neoplastic features of H-RS cells.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX